ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

DNAnexus to Showcase the Power of the Precision Health Data Cloud at ASHG 2023 Annual Meeting

Leading human geneticists and bioinformaticians to share latest multimodal data-driven insights that can help accelerate collaborative discovery

DNAnexus, Inc., the premier precision health data cloud provider, today announced the speaker lineup for its presentations at the American Society of Human Genetics (ASHG) Annual Meeting 2023, which is being held in Washington, D.C., this week. The company will be showcasing its Precision Health Data Cloud and large-scale analysis tools in booth #1802.

The DNAnexus Precision Health Data Cloud allows researchers to store, access, and explore large sets of proteomic, transcriptomic, genomic, phenotypic, imaging, and other structured data. The comprehensive platform currently has more than 45,000 registered users across 48 countries. In addition, DNAnexus actively manages and supports more than 80 petabytes of complex datasets on behalf of a growing network of collaborators. The platform meets the most rigorous industry standards for data quality, security, privacy, and regulatory compliance.

“DNAnexus has built the only secure and scalable Precision Health Data Cloud capable of managing, analyzing, and collaborating on large-scale multimodal biomedical datasets,” said Thomas Laur, CEO at DNAnexus. “We are looking forward to meeting with the human genetics community at ASHG and sharing how we are empowering our growing network of collaborators to unlock the next wave of critical insights that will accelerate scientific discoveries and improve patient care.”

DNAnexus ASHG 2023 Presentations

Sequencing and Analyzing Whole Genome Data from 500,000 UK Biobank Volunteer Participants

Friday, Nov. 3, 2023; 3:45 pm – 4:14 pm in CoLab Theater 2

FEATURED PRESENTERS:

  • Lucy Burkitt-Gray, PhD, Lead Data Analyst at UK Biobank
  • Ben Busby, PhD, Principal Scientist at DNAnexus

Unlocking Precision Health Insights with DNAnexus: Bridging the Data Divide for Collaborative Discovery

Saturday, Nov. 4, 2023; 12:00 pm – 1:00 pm (Lunch provided) in Room 140AB

FEATURED PRESENTERS:

  • Samir Courdy, Senior Vice President and Chief Informatics Officer at City of Hope
  • Jeffrey Wiser, Senior Director of Product at DNAnexus
  • Matthew Andreatta, PhD, Director of Solution Science at DNAnexus

To register in advance for these presentations, please visit: https://www.dnanexus.com/2023-ashg-ukb-colab.

About DNAnexus

DNAnexus enables biomedical organizations to accelerate scientific discovery and improve patient care with the Precision Health Data Cloud. The company provides scientific innovators and healthcare professionals with the ability to manage, analyze, and collaborate on multi-omic, clinical and real-world data to unlock insights. DNAnexus actively manages more than 80 petabytes of data on behalf of a growing network of collaborations with leading pharmaceutical, clinical diagnostic, academic research, biobank, and government organizations. Today, more than 45,000 users across 48 countries and over 130 enterprise customers are harnessing the full potential of their data with the scalable and secure Precision Health Data Cloud. DNAnexus is headquartered in Mountain View, Calif. For more information, visit www.dnanexus.com or follow @DNAnexus.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.22
+21.36 (9.58%)
AAPL  270.37
-1.03 (-0.38%)
AMD  256.12
+1.28 (0.50%)
BAC  53.45
+0.42 (0.79%)
GOOG  281.82
-0.08 (-0.03%)
META  648.35
-18.12 (-2.72%)
MSFT  517.81
-7.95 (-1.51%)
NVDA  202.49
-0.40 (-0.20%)
ORCL  262.61
+5.72 (2.23%)
TSLA  456.56
+16.46 (3.74%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.